提高癌症诊所低负担护理点烟草治疗计划的覆盖面和有效性。

IF 6.3 2区 社会学 Q1 INTERNATIONAL RELATIONS
Alex T Ramsey, Timothy B Baker, Faith Stoneking, Nina Smock, Jingling Chen, Giang Pham, Aimee S James, Graham A Colditz, Ramaswamy Govindan, Laura J Bierut, Li-Shiun Chen
{"title":"提高癌症诊所低负担护理点烟草治疗计划的覆盖面和有效性。","authors":"Alex T Ramsey, Timothy B Baker, Faith Stoneking, Nina Smock, Jingling Chen, Giang Pham, Aimee S James, Graham A Colditz, Ramaswamy Govindan, Laura J Bierut, Li-Shiun Chen","doi":"10.6004/jnccn.2021.7333","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Tobacco cessation after a cancer diagnosis can extend patient survival by improving outcomes for primary cancer and preventing secondary cancers. However, smoking is often unaddressed in cancer care, highlighting the need for strategies to increase treatment reach and cessation. This study examined a low-burden, point-of-care tobacco treatment program (ELEVATE) featuring an electronic health record-enabled smoking module and decision support tools to increase the reach and effectiveness of evidence-based smoking cessation treatment.</p><p><strong>Methods: </strong>This study included adult outpatient tobacco smokers (n=13,651) in medical oncology, internal medicine, and surgical oncology clinics from a large midwestern healthcare system. We examined reach and effectiveness of ELEVATE with 2 comparisons: (1) preimplementation versus postimplementation of ELEVATE and (2) ELEVATE versus usual care. Data were evaluated during 2 time periods: preimplementation (January through May 2018) and postimplementation (June through December 2018), with smoking cessation assessed at the last follow-up outpatient encounter during the 6 months after these periods.</p><p><strong>Results: </strong>The proportion of current tobacco smokers receiving cessation treatment increased from pre-ELEVATE to post-ELEVATE (1.6%-27.9%; difference, 26.3%; relative risk, 16.9 [95% CI, 9.8-29.2]; P<.001). Compared with 27.9% treatment reach with ELEVATE in the postimplementation time period, reach within usual care clinics ranged from 11.8% to 12.0% during this same period. The proportion of tobacco smokers who subsequently achieved cessation increased significantly from pre-ELEVATE to post-ELEVATE (12.0% vs 17.2%; difference, 5.2%; relative risk, 1.3 [95% CI, 1.1-1.5]; P=.002). Compared with 17.2% smoking cessation with ELEVATE in the postimplementation time period, achievement of cessation within usual care clinics ranged from 8.2% to 9.9% during this same period.</p><p><strong>Conclusions: </strong>A low-burden, point-of-care tobacco treatment strategy increased tobacco treatment and cessation, thereby improving access to and the impact of evidence-based cessation treatment. Using implementation strategies to embed tobacco treatment in every healthcare encounter promises to engage more smokers in evidence-based treatment and facilitate smoking cessation, thereby improving care cancer for patients who smoke.</p>","PeriodicalId":12371,"journal":{"name":"Foreign Affairs","volume":"73 1","pages":"488-495.e4"},"PeriodicalIF":6.3000,"publicationDate":"2022-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9173433/pdf/","citationCount":"0","resultStr":"{\"title\":\"Increased Reach and Effectiveness With a Low-Burden Point-of-Care Tobacco Treatment Program in Cancer Clinics.\",\"authors\":\"Alex T Ramsey, Timothy B Baker, Faith Stoneking, Nina Smock, Jingling Chen, Giang Pham, Aimee S James, Graham A Colditz, Ramaswamy Govindan, Laura J Bierut, Li-Shiun Chen\",\"doi\":\"10.6004/jnccn.2021.7333\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Tobacco cessation after a cancer diagnosis can extend patient survival by improving outcomes for primary cancer and preventing secondary cancers. However, smoking is often unaddressed in cancer care, highlighting the need for strategies to increase treatment reach and cessation. This study examined a low-burden, point-of-care tobacco treatment program (ELEVATE) featuring an electronic health record-enabled smoking module and decision support tools to increase the reach and effectiveness of evidence-based smoking cessation treatment.</p><p><strong>Methods: </strong>This study included adult outpatient tobacco smokers (n=13,651) in medical oncology, internal medicine, and surgical oncology clinics from a large midwestern healthcare system. We examined reach and effectiveness of ELEVATE with 2 comparisons: (1) preimplementation versus postimplementation of ELEVATE and (2) ELEVATE versus usual care. Data were evaluated during 2 time periods: preimplementation (January through May 2018) and postimplementation (June through December 2018), with smoking cessation assessed at the last follow-up outpatient encounter during the 6 months after these periods.</p><p><strong>Results: </strong>The proportion of current tobacco smokers receiving cessation treatment increased from pre-ELEVATE to post-ELEVATE (1.6%-27.9%; difference, 26.3%; relative risk, 16.9 [95% CI, 9.8-29.2]; P<.001). Compared with 27.9% treatment reach with ELEVATE in the postimplementation time period, reach within usual care clinics ranged from 11.8% to 12.0% during this same period. The proportion of tobacco smokers who subsequently achieved cessation increased significantly from pre-ELEVATE to post-ELEVATE (12.0% vs 17.2%; difference, 5.2%; relative risk, 1.3 [95% CI, 1.1-1.5]; P=.002). Compared with 17.2% smoking cessation with ELEVATE in the postimplementation time period, achievement of cessation within usual care clinics ranged from 8.2% to 9.9% during this same period.</p><p><strong>Conclusions: </strong>A low-burden, point-of-care tobacco treatment strategy increased tobacco treatment and cessation, thereby improving access to and the impact of evidence-based cessation treatment. Using implementation strategies to embed tobacco treatment in every healthcare encounter promises to engage more smokers in evidence-based treatment and facilitate smoking cessation, thereby improving care cancer for patients who smoke.</p>\",\"PeriodicalId\":12371,\"journal\":{\"name\":\"Foreign Affairs\",\"volume\":\"73 1\",\"pages\":\"488-495.e4\"},\"PeriodicalIF\":6.3000,\"publicationDate\":\"2022-05-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9173433/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Foreign Affairs\",\"FirstCategoryId\":\"90\",\"ListUrlMain\":\"https://doi.org/10.6004/jnccn.2021.7333\",\"RegionNum\":2,\"RegionCategory\":\"社会学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"INTERNATIONAL RELATIONS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Foreign Affairs","FirstCategoryId":"90","ListUrlMain":"https://doi.org/10.6004/jnccn.2021.7333","RegionNum":2,"RegionCategory":"社会学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INTERNATIONAL RELATIONS","Score":null,"Total":0}
引用次数: 0

摘要

背景:癌症确诊后戒烟可改善原发性癌症的治疗效果并预防继发性癌症,从而延长患者的生存期。然而,在癌症治疗过程中,吸烟问题往往得不到解决,这凸显了提高治疗覆盖率和戒烟率策略的必要性。本研究考察了一项低负担、护理点烟草治疗项目(ELEVATE),该项目具有电子健康记录支持的吸烟模块和决策支持工具,可提高循证戒烟治疗的覆盖面和有效性:本研究纳入了中西部大型医疗系统中肿瘤内科、内科和肿瘤外科门诊的成年吸烟者(n=13,651)。我们对 ELEVATE 的覆盖面和有效性进行了两方面的比较:(1) ELEVATE 实施前与实施后的比较;(2) ELEVATE 与常规护理的比较。数据在两个时间段内进行评估:实施前(2018 年 1 月至 5 月)和实施后(2018 年 6 月至 12 月),在这两个时间段后的 6 个月内,在最后一次随访门诊时对戒烟情况进行评估:目前接受戒烟治疗的吸烟者比例从ELEVATE前增加到ELEVATE后(1.6%-27.9%;差异,26.3%;相对风险,16.9 [95% CI,9.8-29.2];PC结论:低负担的护理点烟草治疗策略增加了烟草治疗和戒烟率,从而提高了循证戒烟治疗的可及性和效果。利用实施策略将烟草治疗纳入每一次医疗服务中,有望让更多吸烟者接受循证治疗并促进戒烟,从而改善吸烟患者的护理癌症。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Increased Reach and Effectiveness With a Low-Burden Point-of-Care Tobacco Treatment Program in Cancer Clinics.

Background: Tobacco cessation after a cancer diagnosis can extend patient survival by improving outcomes for primary cancer and preventing secondary cancers. However, smoking is often unaddressed in cancer care, highlighting the need for strategies to increase treatment reach and cessation. This study examined a low-burden, point-of-care tobacco treatment program (ELEVATE) featuring an electronic health record-enabled smoking module and decision support tools to increase the reach and effectiveness of evidence-based smoking cessation treatment.

Methods: This study included adult outpatient tobacco smokers (n=13,651) in medical oncology, internal medicine, and surgical oncology clinics from a large midwestern healthcare system. We examined reach and effectiveness of ELEVATE with 2 comparisons: (1) preimplementation versus postimplementation of ELEVATE and (2) ELEVATE versus usual care. Data were evaluated during 2 time periods: preimplementation (January through May 2018) and postimplementation (June through December 2018), with smoking cessation assessed at the last follow-up outpatient encounter during the 6 months after these periods.

Results: The proportion of current tobacco smokers receiving cessation treatment increased from pre-ELEVATE to post-ELEVATE (1.6%-27.9%; difference, 26.3%; relative risk, 16.9 [95% CI, 9.8-29.2]; P<.001). Compared with 27.9% treatment reach with ELEVATE in the postimplementation time period, reach within usual care clinics ranged from 11.8% to 12.0% during this same period. The proportion of tobacco smokers who subsequently achieved cessation increased significantly from pre-ELEVATE to post-ELEVATE (12.0% vs 17.2%; difference, 5.2%; relative risk, 1.3 [95% CI, 1.1-1.5]; P=.002). Compared with 17.2% smoking cessation with ELEVATE in the postimplementation time period, achievement of cessation within usual care clinics ranged from 8.2% to 9.9% during this same period.

Conclusions: A low-burden, point-of-care tobacco treatment strategy increased tobacco treatment and cessation, thereby improving access to and the impact of evidence-based cessation treatment. Using implementation strategies to embed tobacco treatment in every healthcare encounter promises to engage more smokers in evidence-based treatment and facilitate smoking cessation, thereby improving care cancer for patients who smoke.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Foreign Affairs
Foreign Affairs INTERNATIONAL RELATIONS-
CiteScore
4.80
自引率
0.00%
发文量
2
期刊介绍: Founded in 1922, Foreign Affairs is a prominent American magazine that focuses on international relations and U.S. foreign policy. It is published by the Council on Foreign Relations, an esteemed nonpartisan think tank and membership organization dedicated to analyzing U.S. foreign policy and global affairs. While the print magazine is released every two months, the website offers daily articles and publishes anthologies every other month.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信